Novartis’s everolimus wins US backing as transplant drug | Alrroya

Novartis’s everolimus wins US backing as transplant drug

Tuesday, 8 December 2009  at  10:47, Bloomberg
Novartis AG won the backing of a US advisory panel for its everolimus medicine as a treatment to prevent organ rejection in kidney transplants.








Your comments

The content of this field is kept private and will not be shown publicly.
  • Allowed HTML tags: <b> <i> <a> <em> <strong> <cite> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Lines and paragraphs break automatically.
  • Web page addresses and e-mail addresses turn into links automatically.

More information about formatting options

  • Subscribe to Daily Newsletter More

  • Join Alrroya.com